Camp4 Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Camp4 Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $8.58. The average 1-year stock price forecast is 90.67% higher than the current stock price, while the lowest is $6.50 (+44.44%) and the highest is $12 (+166.67%).

Price Target: $8.58 (+90.67%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.50	$8.58	$8.50	$12
Change	+44.44%	+90.67%	+88.89%	+166.67%

Analyst Ratings

The average analyst rating for Camp4 Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	4	4	4	4	5	5
Buy	1	1	1	1	2	2
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Myles Minter William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Jun 25, 2026
Anupam Rama J.P. Morgan	J.P. Morgan	Buy Upgrades $9	Buy	Upgrades	$9	+100.00%	Jun 23, 2026
Keay Nakae Chardan Capital	Chardan Capital	Buy Initiates $6.5	Buy	Initiates	$6.5	+44.44%	Jun 10, 2026
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Reiterates $12	Buy	Reiterates	$12	+166.67%	May 15, 2026
Yun Zhong Wedbush	Wedbush	Buy Maintains $8	Buy	Maintains	$8	+77.78%	May 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.28M

from 3.50M

79.42%

from 3.50M

Revenue Next Year

6.82M

from 6.28M

8.61%

from 6.28M

EPS This Year

-0.79

from -1.65

EPS Next Year

-0.78

from -0.79

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	350.00K	652.00K	3.50M	6.28M
Revenue Growth	-	-	86.29%	436.50%	79.42%
Operating Income	-45.00M	-51.88M	-53.09M	-52.06M	-57.19M
Net Income	-44.19M	-49.29M	-51.79M	-80.40M	-56.12M
EPS	-	-	-	-1.65	-0.79
Free Cash Flow	-	-30.18M	-26.52M	-20.64M	-51.00M
No. Analysts	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	9.6M
Avg	6.3M
Low	1.3M

Revenue Growth

Revenue Growth	2026	2027	2028
High	174.4%
Avg	79.4%
Low	-63.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.68
Avg	-0.79
Low	-0.97

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-